251 related articles for article (PubMed ID: 2469130)
1. Biological molecules in the treatment of hematological disorders.
Kurzrock R; Talpaz M; Gutterman U
Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
[No Abstract] [Full Text] [Related]
2. Hematopoietic colony-stimulating factors.
Andreeff M; Welte K
Semin Oncol; 1989 Jun; 16(3):211-29. PubMed ID: 2471272
[No Abstract] [Full Text] [Related]
3. Treatment of myelodysplastic syndromes with hemopoietic growth factors.
Greenberg PL
Semin Oncol; 1992 Feb; 19(1):106-14. PubMed ID: 1371018
[No Abstract] [Full Text] [Related]
4. The use of growth factors in severe aplastic anaemia (SAA).
Hinterberger W; Hoffmann S; Bettelheim P; Geissler K; Maurer D; Muhm M
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():129-30. PubMed ID: 2697425
[No Abstract] [Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor and myelodysplastic syndromes.
N Engl J Med; 1988 Jul; 319(1):51-3. PubMed ID: 3288869
[No Abstract] [Full Text] [Related]
6. The basis for treatment of myelodysplastic syndrome and acute nonlymphoblastic leukemia with biologic agents.
Elias L
Leukemia; 1988 Jun; 2(6):400-2. PubMed ID: 2453761
[TBL] [Abstract][Full Text] [Related]
7. [Status of recombinant cytokines in treatment of leukemic diseases].
Geissler K
Wien Med Wochenschr; 1991; 141(9-10):217-20. PubMed ID: 1949848
[TBL] [Abstract][Full Text] [Related]
8. [Recent progress in the treatment of hematological malignancies. III. Management of patients with myelodysplastic syndromes and atypical leukemias].
Yoshida Y
Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):785-8. PubMed ID: 2507717
[No Abstract] [Full Text] [Related]
9. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
[No Abstract] [Full Text] [Related]
10. [Management of myelodysplastic syndromes].
Hotta T
Rinsho Ketsueki; 1990 Apr; 31(4):416-30. PubMed ID: 1696325
[No Abstract] [Full Text] [Related]
11. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
Ganser A; Hoelzer D
Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
[No Abstract] [Full Text] [Related]
12. Bone marrow failure and hematopoietic growth factors.
Douer D
Isr J Med Sci; 1989 Apr; 25(4):183-5. PubMed ID: 2468629
[No Abstract] [Full Text] [Related]
13. [Expectations in the clinical application of human-recombinant cytokines. 4) Interleukin-3 and colony-stimulation factors].
Takaku F
Nihon Rinsho; 1988 May; 46(5):1105-11. PubMed ID: 2457722
[No Abstract] [Full Text] [Related]
14. [Cytokines in clinical use].
Meyer P; Wilms K
Internist (Berl); 1988 Nov; 29(11):717-26. PubMed ID: 2466805
[No Abstract] [Full Text] [Related]
15. Hematopoietic growth factors in the treatment of patients with HIV infection.
Mitsuyasu RT
Biotherapy; 1990; 2(2):173-81. PubMed ID: 1698092
[No Abstract] [Full Text] [Related]
16. Clinical studies with interferons in Philadelphia positive chronic myelogenous leukemia.
Talpaz M; Kantarjian H; Kurzrock R; Gutterman JU
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():63. PubMed ID: 2496883
[No Abstract] [Full Text] [Related]
17. [Stem cell-colony stimulating factors].
Urabe A; Kobayashi Y; Takaku F
Gan No Rinsho; 1989 May; Spec No():287-93. PubMed ID: 2481048
[No Abstract] [Full Text] [Related]
18. Clinical use of growth factors in the myelodysplastic syndromes.
Stein RS
Am J Med Sci; 1994 May; 307(5):360-7. PubMed ID: 7513498
[No Abstract] [Full Text] [Related]
19. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1996; 16():347-75. PubMed ID: 8639390
[No Abstract] [Full Text] [Related]
20. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1990; 11():321-42. PubMed ID: 2223398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
